BIOVAC V
₹1,470.00
Description
BIOVAC V is a preparation of the live, attenuated varicella virus. It is indicated for active immunization for the prevention of Varicella (Chickenpox) in individuals 12 months of age and older.
Immunization Guideline:
Each dose is approximately 0.5 mL after reconstitution and is administered by subcutaneous injection.
- In children (12 months to 12 years of age), 2 doses at a minimum interval of 3 months should be given
- In adolescents (≥13 years of age), 2 dose at a minimum interval of 4 weeks should be given
- In adults 2 doses, to be administered at minimum interval of 4 weeks should be given
Additional information
manufacturer | Wockhardt |
---|---|
package-size | 1 Dose |
pharmaceutical-form | Lyophilized |
route-of-administration | Subcutaneous |
vaccine-type | chickenpox |
Contraindications | History of severe allergic reaction to any component of the vaccine (including neomycin and gelatin) or to a previous dose of varicella vaccine. Primary or acquired immunodeficiency states. Any febrile illness or active infection, including untreated tuberculosis. Pregnancy. |
country-of-manufacture | China |